Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)

BACKGROUND: Locally advanced rectal cancer (LARC) is a heterogeneous group of tumors where a risk-adapted therapeutic strategy is needed. Short-course radiotherapy (SCRT) is a more convenient option for LARC patients than preoperative long-course RT plus capecitabine. Histone-deacetylase inhibitors...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:BMC Cancer
Κύριοι συγγραφείς: Avallone, Antonio, Piccirillo, Maria Carmela, Delrio, Paolo, Pecori, Biagio, Di Gennaro, Elena, Aloj, Luigi, Tatangelo, Fabiana, D’Angelo, Valentina, Granata, Cinzia, Cavalcanti, Ernesta, Maurea, Nicola, Maiolino, Piera, Bianco, Franco, Montano, Massimo, Silvestro, Lucrezia, Terranova Barberio, Manuela, Roca, Maria Serena, Di Maio, Massimo, Marone, Pietro, Botti, Gerardo, Petrillo, Antonella, Daniele, Gennaro, Lastoria, Secondo, Iaffaioli, Vincenzo R, Romano, Giovanni, Caracò, Corradina, Muto, Paolo, Gallo, Ciro, Perrone, Francesco, Budillon, Alfredo
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2014
Θέματα:
Study Protocol
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289397/
https://ncbi.nlm.nih.gov/pubmed/25421252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-875
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια